ReachMD
Be part of the knowledge.™Public Profile
Affiliations
University of California San Francisco, St. Luke's Hospital in San Francisco
DisclosuresDr. Bohannon has received honoraria for speaking engagements from the following: Sanofi-Aventis, Merck, Merck-Schering-Plough, Lilly, Amylin, Qwest Diagnostics, and Novartis. Dr. Bohannon has been paid consultant fees by: Lilly, Novartis, Sanofi-Aventis, Calibra, Veralight, Biodel, Vivus, Johnson and Johnson, Valeritas, Mannkind, Roche and Pfizer. Dr. Bohannon has done research in the last 2 years for Novartis, Lilly, Sanofi-Aventis, Valeritas and Vivas.
Dr. Nancy J.V. Bohannon is director of clinical research at the Cardiovascular Risk Reduction Program at St. Luke's Hospital in San Francisco, and is in full time solo private practice in San Francisco, specializing in research in and treatment of diabetes.
Dr. Bohannon completed an internship and residency in internal medicine at Children's Hospital, San Francisco, and the Dorothy Frank Diabetes clinical/research fellowship at the University of California, San Francisco (UCSF), sponsored by the San Francisco Diabetes Association, prior to becoming an assistant clinical professor at UCSF.